Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight
PolandStudy on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults
PolandStudy on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease
PolandStudy Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration
PolandStudy on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis
PolandStudy on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis
PolandStudy on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment
PolandStudy on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PolandStudy on Sotatercept for Treating Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction
PolandStudy on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity
PolandStudy on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes
PolandStudy Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
